Evidence map›Paper›PMID 11871661›Full record

ArticleRNA (New York, N.Y.)2002

Identification of domains in apobec-1 complementation factor required for RNA binding and apolipoprotein-B mRNA editing.

Anuradha Mehta, Donna M Driscoll

Abstract read
In one paragraph

Article in RNA (New York, N.Y.), 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. RNA Editing-Systemic Relevance and Clue to Disease Mechanisms?Frontiers in molecular neuroscience · 2016
    Review
  20. Identification of DNA cleavage- and recombination-specific hnRNP cofactors for activation-induced cytidine deaminase.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Anuradha MehtaDepartment of Cell Biology, Lerner Research Institute, Cleveland Clinic Foundation, Ohio 44195, USA.
Donna M Driscoll

Funding

EDITING OF APOLIPOPROTEIN-B MRNAR01HL045478 · NHLBI · CLEVELAND CLINIC LERNER COL/MED-CWRU · PI DRISCOLL, DONNA M · 1996 to 2004
$1.2M
EDITING OF APOLIPOPROTEIN B MRNAR29HL045478 · NHLBI · SOUTHWEST FOUNDATION FOR BIOMEDICAL RES · PI DRISCOLL, DONNA M · 1991 to 1995
–
NHLBI NIH HHS HL45478
6 · The paper itself

Abstract

The C-to-U editing of apolipoprotein-B (apo-B) mRNA is catalyzed by an enzyme complex that recognizes an 11-nt mooring sequence downstream of the editing site. A minimal holoenzyme that edits apo-B mRNA in vitro has been defined. This complex contains apobec-1, the catalytic subunit, and apobec-1 complementation factor (ACF), the RNA-binding subunit that binds to the mooring sequence. Here, we show that ACF binds with high affinity to single-stranded but not double-stranded apo-B mRNA. ACF contains three nonidentical RNA recognition motifs (RRM) and a unique C-terminal auxiliary domain. In many multi-RRM proteins, the RRMs mediate RNA binding and an auxiliary domain functions in protein-protein interactions. Here we show that ACF does not fit this simple model. Based on deletion mutagenesis, the RRMs in ACF are necessary but not sufficient for binding to apo-B mRNA. Amino acids in the pre-RRM region are required for complementing activity and RNA binding, but not for interaction with apobec-1. The C-terminal 196 amino acids are not absolutely essential for function. However, further deletion of an RG-rich region from the auxiliary domain abolished complementing activity, RNA binding, and apobec-1 interaction. The auxiliary domain alone did not bind apobec-1. Although all three RRMs are required for complementing activity and apobec-1 interaction, the individual motifs contribute differently to RNA binding. Point mutations in RRM1 or RRM2 decreased the Kd for apo-B mRNA by two orders of magnitude whereas mutations in RRM3 reduced binding affinity 13-fold. The pairwise expression of RRM1 with RRM2 or RRM3 resulted in moderate affinity binding.

Indexed as

Cytidine DeaminaseAmino Acid SequenceAnimalsAPOBEC-1 DeaminaseApolipoproteins BBinding SitesElectrophoretic Mobility Shift AssayGenetic Complementation TestHumansMolecular Sequence DataProtein BindingProtein Structure, TertiaryRatsRNA-Binding ProteinsRNA EditingRNA, MessengerAPOBEC-1 DeaminaseAPOBEC1 protein, humanApobec1 protein, ratApolipoproteins BCytidine DeaminaseRNA-Binding ProteinsRNA, Messenger

Identifiers

PMID11871661
PMCPMC1370230

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.